• 1
    Yoshida T. Use and misuse of amphetamines: an international overview. In: KleeH (ed.). Amphetamine Misuse: International Perspectives on Current Trends. Harwood Academic Publishers, Amsterdam, 1997; 116.
  • 2
    Chou P, Liou MY, Lai MY, Hsiao ML, Chang HJ. Time trend of substance use among adolescent students in Taiwan, 1991–96. J. Formos. Med. Assoc. 1999; 98: 827831.
  • 3
    Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 25112518.
  • 4
    Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982; 39: 161168.
  • 5
    Muesser KT, Yarnold PR, Levinson DF et al. Prevalence of substance abuse in schizophrenia, demographic and clinical correlates. Schizophr. Bull. 1990; 6: 1041.
  • 6
    Selzer JA, Lieberman JA. Schizophrenia and substance abuse. Psychiatr. Clin. North Am. 1993; 16: 401412.
  • 7
    Steinberg JR. Substance abuse and psychosis. In: AncillRJ, HollidayS, HigenbottamJ (eds). Schizophrenia. Exploring the Spectrum of Psychosis. John Wiley and Son, New York, 1994; 259289.
  • 8
    McLellan AT, Druley KA. Non-random relation between drugs of abuse and psychiatric diagnosis. J. Psychiatr. Res. 1977; 13: 179184.
  • 9
    Chen CC, Tsai SY, Su LW, Yang TW, Tsai CJ, Hwu HG. Psychiatric co-morbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction 1999; 94: 825832.
  • 10
    Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Pychiatry 1994; 51: 819.
  • 11
    Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am. J. Psychiatry 1993; 150: 17071711.
  • 12
    Brooner RK, King VL, Kidorf M, Schmidt CW Jr, , Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997; 54: 7180.
  • 13
    Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch. Gen. Psychiatry 1991; 48: 4351.
  • 14
    Griffin ML, Weiss RD, Mirin SM, Lange U. A comparison of male and female cocaine abusers. Arch. Gen. Psychiatry 1989; 46: 122126.
  • 15
    Chen CK, Lin SK, Sham P et al. Premorbid characteristics and comorbidity of methamphetamine users with and without psychosis. Psychol. Med. 2003; 33: 14071414.
  • 16
    Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am. J. Psychiatry 1998; 155: 12141220.
  • 17
    Nurnberger JI Jr, , Blehar MC, Kaufmann CA et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994; 51: 849859.
  • 18
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, 1994.
  • 19
    Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr. Scand. 1989; 79: 136147.
  • 20
    Murray RM, Grech A, Phillips P, Johnson S. What is the relationship between substance abuse and schizophrenia? In: MurrayRM, JonesP, SusserE, Van OsJ, CannonM (eds). The Epidemiology of Schizophrenia. Cambridge University Press, Cambridge, 2003; 317342.
  • 21
    McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 1998; 18: 84178422.
  • 22
    Volkow ND, Chang L, Wang GJ et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 2001; 158: 377384.
  • 23
    Sekine Y, Iyo M, Ouchi Y et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 2001; 158: 12061214.
  • 24
    Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 1985; 142: 12591264.
  • 25
    Turner RJ, Gil AG. Psychiatric and substance use disorders in South Florida: racial/ethnic and gender contrasts in a young adult cohort. Arch. Gen. Psychiatry 2002; 59: 4350.
  • 26
    Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr. Clin. North Am. 1999; 22: 241252.
  • 27
    Lex BW. Gender differences and substance abuse. Adv. Alcohol. Subst. Abuse 1991; 4: 225296.
  • 28
    Lancaster FE. Gender differences in the brain: implications for the study of human alcoholism. Alcohol. Clin. Exp. Res. 1994; 18: 740746.
  • 29
    Chen CK, Shu LW, Liang PL, Hung TM, Lin SK. Drug use patterns and gender differences among heroin addicts hospitalized for detoxification. Changgeng. Yi. Xue. Za Zhi 1998; 21: 172178.
  • 30
    Tatetsu S, Goto A, Fujiwara T. The Methamphetamine Psychosis. Igakushoin, Tokyo, 1956.
  • 31
    Sato M, Chen CC, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiatry 1983; 18: 429440.
  • 32
    Nakatani Y, Yoshizawa F, Yamada H, Iwanami A, Sakaguchi M, Katoh N. Methamphetamine psychosis in Japan: a survey [letter]. Br. J. Addiction 1989; 84: 15481549.
  • 33
    Myers JK, Weissman MM, Tischler GL et al. Six-month prevalence of psychiatric disorders in three communities 1980–82. Arch. Gen. Psychiatry 1984; 41: 959967.